Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pressure For More DTC Ad Regulation Begins Again With PDUFA V

Executive Summary

Industry should be prepared for the fight over user fees for direct-to-consumer advertising to be revived during the fifth round of reauthorization of the Prescription Drug User Fee Act
Advertisement

Related Content

Industry Missing A Public Health Opening With DTC Ads, FDA’s Hamburg Says
Industry Missing A Public Health Opening With DTC Ads, FDA’s Hamburg Says
Mentions Of Family History In DTC Ads Catch Hold, Study Finds
PDUFA V Fight Shifting Into Higher Gear
Generic User Fees Face Opposition From Key House Appropriator DeLauro
Generic User Fees Face Opposition From Key House Appropriator DeLauro
DTC User Fees Rejected By House Approps Panel As FDA Safety Funds Get Boost
Risk Disclosure In Drug Ads Will Be FDA’s Focus After House Defeats DTC Ban
Risk Disclosure In Drug Ads Will Be FDA’s Focus After House Defeats DTC Ban

Topics

Advertisement
UsernamePublicRestriction

Register

PS052143

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel